Logo image
Synthesis and evaluation of tiaprofenic acid-derived UCHL5 deubiquitinase inhibitors
Journal article   Open access   Peer reviewed

Synthesis and evaluation of tiaprofenic acid-derived UCHL5 deubiquitinase inhibitors

Harshani S. Gurusingha Arachchige, Poornima D.H. Herath Mudiyanselage, Garrett C. VanHecke, Kush Patel, Hassan A. Cheaito, Q. Ping Dou and Young-Hoon Ahn
Bioorganic & medicinal chemistry, v 30, 115931
15 Jan 2021
PMID: 33341501
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880549View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Deubiquitinase Proteasome Tiaprofenic acid UCHL5 inhibitor
[Display omitted] The ubiquitin–proteasome system (UPS) plays an important role in maintaining protein homeostasis by degrading intracellular proteins. In the proteasome, poly-ubiquitinated proteins are deubiquitinated by three deubiquitinases (DUBs) associated with 19S regulatory particle before degradation via 20S core particle. Ubiquitin carboxyl-terminal hydrolase L5 (UCHL5) is one of three proteasome-associated DUBs that control the fate of ubiquitinated substrates implicated in cancer survival and progression. In this study, we have performed virtual screening of an FDA approved drug library with UCHL5 and discovered tiaprofenic acid (TA) as a potential binder. With molecular docking analysis and in-vitro DUB assay, we have designed, synthesized, and evaluated a series of TA derivatives for inhibition of UCHL5 activity. We demonstrate that one TA derivative, TAB2, acts as an inhibitor of UCHL5.

Metrics

10 Record Views
5 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemistry & Molecular Biology
Chemistry, Medicinal
Chemistry, Organic
Logo image